Navigation Links
New book further supports controversial theory of 'Man the Hunted'
Date:8/20/2008

rom meat."

Sussman and Hart argue that early man did not have the capacity to detoxify rotting meat nor the ability to chase off competing animal scavengers.

"Not one of the more than 250 living primate species is a scavenger," says Sussman. "They are not scavengers because they avoid decomposing food."

Sussman and Hart also address the topic of cannibalism, which they claim is "beyond rare," and atypical, strange human behavior. "It just hardly ever happens," Sussman says.

The philosophical question of how a new scientific paradigm gets accepted is also discussed. "Once a paradigm becomes established within a scientific community, most practitioners become technicians working within the parameters of the theory but rarely questioning the validity of the theory itself," Sussman writes.

Changing the currently popular Man the Hunter theory is difficult for that reason.

Though Sussman realizes there will still be critics of the Man the Hunted theory, he believes the book's new version will help to quiet some of that.

Early man may have hunted, but was not a hunter. He may have scavenged, but was not a scavenger. Humans evolved mainly as a plant-eating species that ate some animal protein collected opportunistically, Sussman and Hart claim.

"We are not saying that our theory is absolutely correct and will never be disproven," he says "But we are saying that the evidence we have today best fits the theory of Man the Hunted than of Man the Hunter."

Background on the original 'Man the Hunted.'

Sussman's book, "Man the Hunted: Primates, Predators and Human Evolution," poses a new theory, based on the fossil record and living primate species, that primates have been prey for millions of years, a fact that greatly influenced the evolution of early man.

He co-authored the book with Donna L. Hart, Ph.D., a member of the faculty of Pierre Laclede Honors College and the Depa
'/>"/>

Contact: Neil Schoenherr
nschoenherr@wustl.edu
314-935-5235
Washington University in St. Louis
Source:Eurekalert  

Page: 1 2 3 4 5

Related biology news :

1. Further development of Water Framework Directive necessary
2. Further breakthroughs for breast cancer patients
3. Worlds largest investor coalition seeks further disclosure on climate change and shareholder value
4. Immunosuppressant further linked to birth defects
5. New study casts further doubt on risk of death from higher salt intake
6. New CITES quotas allow more caviar export, further jeopardize endangered sturgeon
7. UNC, Caltech research finds further evidence for genetic contribution to autism
8. Grant supports study of abnormal ring-shaped chromosomes
9. Fossil record supports evidence of impending mass extinction
10. Gene study supports single main migration across Bering Strait
11. Study supports reason for concern in childhood and adolescent obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New book further supports controversial theory of 'Man the Hunted'
(Date:5/14/2015)... May 14, 2015 Research and Markets ... "Fingerprint Sensors Market in Smart Mobile Devices " ... believes that 2014 was a watershed year for fingerprint ... of ,Apple Pay,. Apple gave fingerprint sensors a raison ... service. Fingerprint sensors are a must-have feature in flagship ...
(Date:5/11/2015)... Calif. , May 11, 2015  Synaptics ... of human interface solutions, today announced the appointment ... President and Chief Financial Officer, reporting to ... replaces Synaptics, current Chief Financial Officer, Kathleen ... 2014. Mr. Ali brings extensive ...
(Date:5/11/2015)... N.Y. , May 11, 2015 Curemark ... announced the start of a new Phase III double ... of its novel formulation, CM-AT, on all children ages ... of its FDA Phase III double blinded clinical trial ... had low levels of the digestive enzyme chymotrypsin. This ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... of an unknown perpetrator who has committed a crime will ... MC scientists, in collaboration with their Polish colleagues, have discovered ... color. Their findings will be published today in the Springer ... that on the basis of DNA information it is possible ...
... (PHILADELPHIA) An international team of researchers led ... Penn Medicine,s Institute for Translational Medicine and Therapeutics, ... Paris-based Fondation Leducq to study the molecular genetics ... Mechanisms of Novel Genes Associated with Plasma Lipids ...
... Many young people who,ve just learned that they have cancer ... lives could rob them of their ability ever to have ... population: Of the 1.5 million people diagnosed with cancer in ... The good news, according to an article in ...
Cached Biology News:Hair color of unknown offenders is no longer a secret 2Penn Medicine researcher receives $6 million grant for cardiovascular disease study 2Advancements in fertility preservation provide oncology patients new options 2Advancements in fertility preservation provide oncology patients new options 3
(Date:6/1/2015)... June 1, 2015  Fennec Pharmaceuticals, Inc. (TSX: ... interim results from a poster presented today entitled, ... randomised phase III trial of the efficacy of ... receiving cisplatin (Cis) monotherapy for standard risk hepatoblastoma ... Society of Clinical Oncology (ASCO) 2015 Annual Meeting ...
(Date:6/1/2015)... , ROCHESTER, Minn. and ... 2015 Baxter Ventures, the venture arm of ... Clinic and Velocity Pharmaceutical Development, LLC ("VPD") today announced ... a unique collaboration model initiated by Baxter Ventures to ... in the areas of immunology, hematology, and oncology. Following ...
(Date:6/1/2015)... Esperance Pharmaceuticals Inc. today reported positive results ... in ovarian cancer patients resistant to paclitaxel. EP-100 is ... cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors ... wide range of cancers. Results of ... were presented at the 2015 ASCO Annual Meeting ...
(Date:6/1/2015)... 2015 Research and Markets ( ... the "2015 Strategies in European Immunoprotein ... offering. This new 273-page report ... market, including emerging tests, technologies, instrumentation, sales ... leading suppliers. Companies Mentioned: ...
Breaking Biology Technology:Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 2Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 3Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 4Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 2Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 3Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 4Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 5Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3
... - CEO Michael V. Novinski to Discuss Plans ... CEDAR KNOLLS, N.J., Jan. 31 Emisphere,Technologies, Inc. ... will host a,teleconference on Thursday, February 7, at ... V. Novinski will discuss the company,s,emerging business strategy. ...
... Names Board of Directors, SAN DIEGO, Jan. ... developing therapeutics for the,treatment of Alzheimer,s disease, announced ... Series A round of financing. The financing was ... Alta Partners. Additional,investors included AgeChem Venture Fund, and ...
... Foundation Continues Research Initiatives in Search of a Cure and Therapies ... ... N.J., Jan. 31 The Christopher and Dana,Reeve Foundation (CDRF), which ... improving the quality of life for people,living with paralysis through grants, ...
Cached Biology Technology:Emisphere to Host Business Strategy Conference Call on February 7 2Emisphere to Host Business Strategy Conference Call on February 7 3Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments 2Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments 3Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 2Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 3
... Science LAS-3000 imaging system combines new ... user interface, providing significantly improved system ... modularities. The system is especially dedicated ... standard system for Western blotting applications.,Fuiji's ...
This pump accomodates StemSep ; pump feed columns of the following sizes : 0.3in., 0.5in., 0.6in., and 1.0in.....
... m7G Capping system features the ... of the components needed to ... the end of di- or ... feature high efficiency capping (virtually ...
... Removal , , Removes ... cross-reactivity with other proteins , Simple, just ... Economical new surface technology, not based on ... with protein analysis. SurfactAway offers a simple ...
Biology Products: